Clinical Trial Update: Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating Artesunate suppositories for HIV-negative patients with intra-anal HSIL/AIN 2/3 and related HPV-associ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Dysplasia
• Anal Intraepithelial Neoplasia
• Anal Precancerous Condition
• Human Papillomavirus Disease
• Human Papillomavirus Infection

Drugs mentioned

• Artesunate suppositories (artesunate)

Snippet

Sponsor: Frantz Viral Therapeutics, LLC | Conditions: Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition | Phase 2 | Status: ACTIVE_NOT_RECRUITING